Ocular Therapeutix(FRA) 0OT

Market Cap€1.98B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€8.70

-2.79%

-0.25Today

Ocular Therapeutix Financials at a Glance

Market Cap

€1.98B

Revenue (TTM)

€44.64

Net Income (TTM)

-€258.43

EPS (TTM)

-€1.21

P/E Ratio

-7.43

Dividend

€0.00

Beta (Volatility)

-0.11 (Low)

Dividend

€0.00

Beta (Volatility)

-0.11 (Low)

Price

€8.70

Volume

Open

€8.85

Price

€8.70

Volume

Open

€8.85

Previous Close

€8.70

Daily Range

€8.70 - €8.85

52-Week Range

€5.68 - €13.51

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.11 (Low)

Price

€8.70

Volume

Open

€8.85

Previous Close

€8.70

Daily Range

€8.70 - €8.85

52-Week Range

€5.68 - €13.51

Estimated Earnings Date

N/A

0OT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ocular Therapeutix

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Industry

Pharmaceuticals

Sector

Health Care

Employees

325

CEO

Pravin U. Dugel, MD

Website

www.ocutx.com

0OT Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-72.24%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-13.46%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€1.98B

Shares Outstanding

219.62M

Volume

Avg. Volume

27.212

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Ocular Therapeutix Performance Analysis

Ocular Therapeutix annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 48,996,440	33.1%
2023	2023-12-31	EUR 54,058,049	10.3%
2024	2024-12-31	EUR 58,910,552	9.0%
2025	2025-12-31	EUR 46,032,266	-21.9%

Ocular Therapeutix annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.88	6.4%
2023	2023-12-31	EUR -0.94	6.9%
2024	2024-12-31	EUR -1.13	20.3%
2025	2025-12-31	EUR -1.26	11.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€11.59

+1.0%

Gross Profit

€9.86

+1.0%

Gross Margin

85.08%

+1.0%

Market Cap

€1.98B

N/A

Market Cap/Employee

€5.76

N/A

Employees

325

N/A

Net Income

-€67.74

+1.1%

EBITDA

-€69.03

+1.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€593.04

+48.7%

Total Debt

€69.43

+1.1%

Accounts Receivable

€26.47

+1.0%

Inventory

€3.35

+1.3%

Long Term Debt

€66.70

+1.1%

Short Term Debt

€2.73

+1.2%

Return on Assets

-53.19%

+1.2%

Return on Invested Capital

-42.24%

+0.7%

Free Cash Flow

-€61.13

+1.3%

Operating Cash Flow

-€58.21

+1.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 0OT

What is the current price of Ocular Therapeutix?

Ocular Therapeutix is trading at €8.70 per share.

What is the 52-week range for Ocular Therapeutix?

Over the past 52 weeks, Ocular Therapeutix has traded between €5.68 and €13.51.

How much debt does Ocular Therapeutix have?

As of the most recent reporting period, Ocular Therapeutix reported total debt of €69.43M.

How much cash does Ocular Therapeutix have on hand?

Ocular Therapeutix reported €523.61M in cash and cash equivalents in its most recent financial results.

What is Ocular Therapeutix’s dividend yield?

Ocular Therapeutix does not currently have a dividend yield.

Ocular Therapeutix(FRA) 0OT

Ocular Therapeutix Financials at a Glance

0OT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ocular Therapeutix

0OT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ocular Therapeutix Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 0OT

What is the current price of Ocular Therapeutix?

What is the 52-week range for Ocular Therapeutix?

How much debt does Ocular Therapeutix have?

How much cash does Ocular Therapeutix have on hand?

What is Ocular Therapeutix’s dividend yield?

Premium Investing Services